Literature DB >> 28255734

Robot-assisted laparoscopic transperitoneal infrarenal lymphadenectomy in patients with locally advanced cervical cancer by single docking: Do we need a backup procedure?

Fatih Gucer1, Selim Misirlioglu2, Nuri Ceydeli1, Cagatay Taskiran3.   

Abstract

To present our initial experience on the feasibility of robotic transperitoneal para-aortic lymphadenectomy up to left renal vein via single docking approach by high port insertion technique followed by left shoulder docking as a rescue backup procedure in surgically obstructed patients undergoing surgical staging because of locally advanced cervical cancer (LACC). Prospective observational preliminary study. Canadian Task Force classification II-3. Tertiary-care academic affiliated private hospital. Ten patients with LACC who underwent robotic transperitoneal infrarenal para-aortic lymphadenectomy between January 2012 and December 2014. All patients with pathologically proven cervical cancer underwent a PET/CT scanning in a similar fashion at the department of nuclear medicine. PET/CT scans were evaluated by the nuclear medicine specialist. Following pre-operative work-up, robot-assisted transperitoneal infrarenal para-aortic lymphadenectomy was performed up to left renal vein by the same experienced surgeon. Sections of 5 mm were performed and stained with routine hematoxylin and eosin (H&E), and node count was done separately by experienced gynecopathologist. During the study period, 12 consecutive patients with LACC were counseled for pre-therapeutic robot-assisted transperitoneal para-aortic lymphadenectomy. Two patients declined the procedure and underwent standardized chemo-radiation therapy whereas remaining ten patients constituted the study group. In the study group, the median age was 46 years (range 33-59 years), and the median body mass index 28.5 kg/m2 (range 18.5-35.1 kg/m2). Clinical staging was stage IIB in four patients, IIIB in four, and IVA in one. Histopathological diagnosis was squamous cell carcinoma in nine patients, and adenocarcinoma in one. On PET/CT scans, seven out of ten patients were positive for pelvic lymph node metastasis. With respect to para-aortic area, only one of the ten patients had suspected metastasis in PET/CT. For nine patients with LACC, the median docking time was 6.5 min (range 4-15 min), and the median operating time for para-aortic lymphadenectomy was 120 min (range 60-165 min). The median trocar time was 14.5 min (range 5-45 min). In two out of ten patients, the surgical removal of whole lymphatic tissue between inferior mesenteric artery and left renal vein was not completely possible by a single docking of robotic column. Therefore, a new optic trocar was placed in the umbilicus and the robotic column was relocated over the left shoulder of the patient and residual lymphatic tissue measuring approximately 2 cm in the long axis immediately below the left renal vein was removed and the surgery was completed up to the left renal vein. All para-aortic lymphadenectomies have been completed by robotic route. There were no intra-operative complications. No patient received a blood transfusion. Early post-operative grade 2 and 3a complications according to Dindo classification occurred in two patients: one symptomatic lymphocyst and one local infection on assistant port site in one patient. The patient with suspected para-aortic lymph node metastasis in PET/CT showed no metastatic disease on histopathologic exam of para-aortic lymph nodes. The patient with recurrent disease and negative para-aortic lymph nodes on frozen section examination underwent robot-assisted total pelvic exenteration. Five of the residual eight patients had histologically proven metastasis in the para-aortic lymph node(s). Treatment modification occurred in six patients related to pre-treatment staging surgery. According to pathological results, extended field radiation therapy has been added in five patients and it was omitted in one patient. The median time interval between surgery and initiation of radiotherapy was 12 days (range 6-23 days). Robotic transperitoneal infrarenal para-aortic lymphadenectomy up to left renal vein by high port insertion technique is a safe and feasible option for staging and treatment planning. However, technically, it is obstructed in a small group of patients and nodal staging surgery up to left renal vein can be completed by consecutive left shoulder docking approach as a backup rescue plan.

Entities:  

Keywords:  Para-aortic lymphadenectomy; Robotic surgery; Tansperitoneal

Mesh:

Year:  2017        PMID: 28255734     DOI: 10.1007/s11701-017-0685-1

Source DB:  PubMed          Journal:  J Robot Surg        ISSN: 1863-2483


  39 in total

Review 1.  Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.

Authors:  Elly Brockbank; Fani Kokka; Andrew Bryant; Christophe Pomel; Karina Reynolds
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

2.  Robotic extraperitoneal aortic lymphadenectomy: Development of a technique.

Authors:  Javier F Magrina; Rosanne Kho; Regina P Montero; Paul M Magtibay; Wojciech Pawlina
Journal:  Gynecol Oncol       Date:  2009-01-21       Impact factor: 5.482

3.  Comparison of robotic-assisted vs conventional laparoscopy for extraperitoneal paraaortic lymphadenectomy.

Authors:  B Díaz-Feijoo; B Gil-Ibáñez; A Pérez-Benavente; X Martínez-Gómez; E Colás; J L Sánchez-Iglesias; S Cabrera-Díaz; O Puig-Puig; J F Magrina; A Gil-Moreno
Journal:  Gynecol Oncol       Date:  2013-11-11       Impact factor: 5.482

Review 4.  Nodal-staging surgery for locally advanced cervical cancer in the era of PET.

Authors:  Sebastien Gouy; Philippe Morice; Fabrice Narducci; Catherine Uzan; Jennifer Gilmore; Hélène Kolesnikov-Gauthier; Denis Querleu; Christine Haie-Meder; Eric Leblanc
Journal:  Lancet Oncol       Date:  2012-05       Impact factor: 41.316

5.  Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?

Authors:  Simone Marnitz; Christhardt Köhler; Christina Roth; Jürgen Füller; Wolfgang Hinkelbein; Achim Schneider
Journal:  Gynecol Oncol       Date:  2005-08-29       Impact factor: 5.482

6.  Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings.

Authors:  Pedro T Ramirez; Anuja Jhingran; Homer A Macapinlac; Elizabeth D Euscher; Mark F Munsell; Robert L Coleman; Pamela T Soliman; Kathleen M Schmeler; Michael Frumovitz; Lois M Ramondetta
Journal:  Cancer       Date:  2010-11-16       Impact factor: 6.860

7.  Laparoscopic staging in locally advanced cervical carcinoma: A new possible philosophy?

Authors:  J Vidaurreta; A Bermúdez; G di Paola; J Sardi
Journal:  Gynecol Oncol       Date:  1999-12       Impact factor: 5.482

8.  Robotic infrarenal paraaortic and pelvic nodal staging for endometrial cancer: feasibility and lymphatic complications.

Authors:  Barbara Geppert; Jan Persson
Journal:  Acta Obstet Gynecol Scand       Date:  2015-08-25       Impact factor: 3.636

9.  Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study.

Authors:  Michael A Gold; Chunqiao Tian; Charles W Whitney; Peter G Rose; Rachelle Lanciano
Journal:  Cancer       Date:  2008-05-01       Impact factor: 6.860

Review 10.  New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.

Authors:  Nicolas Magné; Cyrus Chargari; Lisa Vicenzi; Norman Gillion; Taha Messai; Jacques Magné; Gérald Bonardel; Christine Haie-Meder
Journal:  Cancer Treat Rev       Date:  2008-10-11       Impact factor: 12.111

View more
  1 in total

Review 1.  Conventional Laparoscopy versus Robotic-Assisted Aortic Lymph-Nodal Staging for Locally Advanced Cervical Cancer: A Systematic Review and Meta-Analysis.

Authors:  Mariano Catello Di Donna; Vincenzo Giallombardo; Giuseppina Lo Balbo; Giuseppe Cucinella; Giulio Sozzi; Vito Andrea Capozzi; Antonino Abbate; Antonio Simone Laganà; Simone Garzon; Vito Chiantera
Journal:  J Clin Med       Date:  2022-06-10       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.